+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Underusage of anticoagulant therapy in nonvalvular atrial fibrillation Analysis of a Hungarian cohort



Underusage of anticoagulant therapy in nonvalvular atrial fibrillation Analysis of a Hungarian cohort



Orvosi Hetilap 145(10): 517-520



In nonvalvular atrial fibrillation stroke prevention by anticoagulation is clearly recommended by evidence based medicine. Underusage of coumarin treatment however is a general problem. The aim of this study was the analysis of prehospital and hospital practice of anticoagulant therapy in a Hungarian cohort. 106 consecutive patients hospitalized in a Budapest medical department with chronic non-valvular atrial fibrillation were included. Mean age was 76 years, the percentage of males was 30%. High stroke risk factors were found in all patients, at least two of them in 72%. 70% of patients were 75 years old or more. Thus anticoagulant treatment was indicated in all patients, however at admission only 30% were anticoagulated, moreover therapeutic range was achieved in only 28% of them. At discharge in 77% of all patients and in 82% without contraindications coumarin treatment could be started, practically independently of age. Conclusions: in the Hungarian prehospital practice anticoagulant treatment of nonvalvular atrial fibrillation is underused and inefficient, but excellent rates even in international comparison can be achieved by adequate medical approach even in the elderly.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 036004170

Download citation: RISBibTeXText


Related references

Use of anticoagulant therapy in non-valvular atrial fibrillation. Analysis of a Hungarian cohort. Orvosi Hetilap 145(10): 517-520, 2004

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation. Circulation. Cardiovascular Quality and Outcomes 8(2 Suppl 1): S12-S20, 2015

OP-244 Warfarin Use in Patients with Nonvalvular Atrial Fibrillation: Analysis From A A Nationwide Cohort-TRAF (Turkish Atrial Fibrillation Data Base). American Journal of Cardiology 113(7): S53-S54, 2014

Physician's fear of anticoagulant therapy in nonvalvular atrial fibrillation. American Journal of the Medical Sciences 348(6): 513-521, 2015

Oral Anticoagulant Therapy at Elderly Age: Heart Failure and Nonvalvular Atrial Fibrillation. American Journal of Geriatric Cardiology 5(1): 78-83, 1996

Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy. Thrombosis and Haemostasis 75(2): 219-223, 1996

Detecting nonvalvular atrial fibrillation and anticoagulant therapy in cardioembolic ischemic stroke. Postgraduate Medicine 128(6): 620-628, 2017

Recurrent cerebral embolism and impending detachment of a previous nonmobile left atrial thrombus following initiation of anticoagulant therapy in a patient with nonvalvular atrial fibrillation. Echocardiography 18(6): 527-529, 2001

Late recurrence of embolic stroke after discontinuation of anticoagulant therapy in nonvalvular atrial fibrillation. Journal of Neurology 235(8): 499-500, 1988

Very low-intensity anticoagulant therapy in elderly cardioembolic stroke patients with nonvalvular atrial fibrillation. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 31(9): 711-715, 1994

Healthcare resources and needs in anticoagulant therapy for patients with nonvalvular atrial fibrillation. SAMOA Study. Revista Clinica Espanola 217(4): 193-200, 2017

Nonvalvular Atrial Fibrillation and Diabetic Nephropathy: Epidemiology, Prognosis, and Choice of Anticoagulant Therapy. Kardiologiia 58(4): 81-95, 2019

Nonvalvular Atrial Fibrillation and Diabetic Nephropathy: Epidemiology, Prognosis, and Choice of Anticoagulant Therapy. Kardiologiia 2018(4): 81-95, 2018

Predictors of anticoagulant treatment in patients with nonvalvular atrial fibrillation: results from atrial fibrillation in Turkey: epidemiologic registry. Clinical and Applied Thrombosis/Hemostasis 21(2): 144-148, 2016

Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation. Acc Current Journal Review 14(2): 59-0, 2005